WHO ICTRP trial
Remote ischemic preconditioning to reduce contrast-induced nephropathy.
NL-OMON37244 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON37244 |
|---|---|
| Public title | Remote ischemic preconditioning to reduce contrast-induced nephropathy. |
| Scientific title | Remote ischemic preconditioning to reduce contrast-induced nephropathy. - RIPCIN study |
| Primary sponsor | Universitair Medisch Centrum Sint Radboud |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Netherlands |
| Conditions | contrast-induced kidney injury contrast-induced nephropathy;10029149;contrast-induced kidney injury;contrast-induced nephropathy |
| Interventions | After informed consent, the researcher checks the scheduled time of the diagnostic and/or therapeutic procedure with iodine-containing contrast at the department of (interventional) radiology. The researcher is present at the angiography… |
| Registration date | Oct 16, 2012 |
| Target size | 76 |
| Secondary IDs | NL41890.091.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: